Period Ending | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 | Mar 30, 2012 |
---|
Total Revenue
|
8,164,000
|
6,842,000
|
6,744,000
|
6,979,000
| Cost of Revenue | 4,436,000 | 3,657,000 | 3,865,000 | 3,976,000 | |
Gross Profit
|
3,728,000
|
3,185,000
|
2,879,000
|
3,003,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 1,641,000 | 1,511,000 | 1,564,000 | 1,617,000 |
|
Non Recurring | 39,000 | 38,000 | 150,000 | 78,000 |
|
Others | 70,000 | 57,000 | 60,000 | 61,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
2,027,000
|
1,581,000
|
1,063,000
|
1,247,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (20,000) | (5,000) | (89,000) |
-
|
|
Earnings Before Interest And Taxes | 1,958,000 | 1,574,000 | 1,016,000 | 1,247,000 |
|
Interest Expense | 307,000 | 318,000 | 308,000 | 320,000 |
|
Income Before Tax | 1,651,000 | 1,256,000 | 708,000 | 927,000 |
|
Income Tax Expense | 483,000 | 418,000 | 279,000 | 346,000 |
|
Minority Interest |
-
|
-
| 1,000 | 2,000 |
|
|
|
Net Income From Continuing Ops | 1,168,000 | 838,000 | 430,000 | 583,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
1,168,000
|
838,000
|
430,000
|
583,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
1,168,000
|
838,000
|
430,000
|
583,000
|
|